American Cancer Society Institutional Research Grants
The American Cancer Society Institutional Research Grant Provides "Seed Money" to Support New Investigators
This is the 14th year of an American Cancer Society Institutional Research Grant (ACS IRG) that was awarded to the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) to support promising new research by junior faculty members.
The principal investigator of the IRG is Stuart S. Martin, Ph.D., Professor of Physiology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine.
The Spring deadline for the ACS-IRG applications is May 1st, 2019 by 4:00pm.
Only junior level faculty members are eligible for the ACS IRG. Junior investigators are faculty within 6 years of their first independent faculty appointment or equivalent (e.g., Instructor, Assistant Professor, and Research Assistant Professor). Investigators who have already received a peer-reviewed national research grant are not eligible to apply. NIH Career Development (K) awards do not count as peer-reviewed national research grants for this purpose. Investigators who have received prior support from the ACS Institutional Research Grant are not eligible.
Non-faculty (e.g., residents, fellows) are not eligible.
New Rule as of 2018: The ACS has changed the eligibility requirement. US citizenship is no longer a requirement. However, if not a US Citizen, the applicant must have a VISA that will cover the time needed to complete the project. Applicants who are not U.S. citizens are welcome to apply.
New for 2017 Funding: We will be funding three (3) projects this year at $30,000 each. Cancer-Related and Cancer Disparities pilot projects will both be competing for one (1) of these awards. Information and application forms are attached.
Cancer-Related pilot projects are relevant to any aspect of basic, translational, and clinical cancer research. ($30,000 maximum per project)
Cancer Disparities pilot projects focus on poor or underserved populations and address a variety of clinical, cancer control, behavioral, epidemiologic, health policy, health services, and basic science issues. ($30,000 total maximum per project)